MATERIAL SAFETY DATA SHEET - Illumina
MATERIAL SAFETY DATA SHEET - Illumina
MATERIAL SAFETY DATA SHEET - Illumina
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Infinium II Assay System Reagents <strong>Illumina</strong> Doc. # 11195131, Rev. H Page 8 of 27<br />
8. EXPOSURE CONTROLS - PERSONAL PROTECTION (Continued)<br />
EXPOSURE LIMITS/CONTROL PARAMETERS (continued):<br />
CHEMICAL NAME CAS # EXPOSURE LIMITS IN AIR<br />
COMPONENT 1: Code WG#-AMM (continued)<br />
ACGIH-TLVs OSHA-PELs NIOSH-RELs NIOSH OTHER<br />
TWA STEL TWA STEL TWA STEL IDLH<br />
mg/m 3 mg/m 3 mg/m 3 mg/m 3 mg/m 3 mg/m 3 mg/m 3 mg/m 3<br />
Alkanolamine NE NE NE NE NE NE NE NE<br />
COMPONENT 3: Code WG#-FRG<br />
Aliphatic Triol 10<br />
(mist)<br />
NE<br />
15 (total dust)<br />
5 (resp. frac.)<br />
10 (total dust)<br />
5 (resp. frac.)<br />
[vacated<br />
1989 PEL]<br />
Carbohydrate 10 NE 15 (total<br />
dust); 5 (resp.<br />
frac.)<br />
COMPONENT 4: Code WG#-PA1<br />
NE NE NE NE DFG MAKs:<br />
TWA = 50<br />
(inhalable<br />
fraction)<br />
PEAK = 2•MAK<br />
15 min. average<br />
value, 1-hr<br />
interval, 4 per<br />
shift<br />
Pregnancy Risk<br />
Group C<br />
NE 10 (total NE NE NE<br />
dust); 5<br />
(resp. frac.<br />
Acetate Salt NE NE NE NE NE NE NE NE<br />
Carboxilic Acid Salt NE NE NE NE NE NE NE NE<br />
COMPONENT 5: Code WG#-RA1<br />
Aliphatic Amide 18<br />
(skin)<br />
NE 15 (skin) NE NE NE NE DFG MAK:<br />
Danger of<br />
cutaneous<br />
absorption<br />
Dibasic Potassium Salt NE NE NE NE NE NE NE NE<br />
Monobasic Potassium Salt NE NE NE NE NE NE NE NE<br />
Sodium Salt NE NE NE NE NE NE NE NE<br />
COMPONENT 7: Code WG#-PB2<br />
Aliphatic Diol NE NE NE NE NE NE NE AIHA WEELs:<br />
TWA = 10<br />
COMPONENT 8: Code WG#-MA1<br />
Refined Hydrocarbon<br />
5 (inhal. NE NE NE NE NE NE NE<br />
frac.)<br />
COMPONENT 9: Code WG#-WB1<br />
Aliphatic Amide 18<br />
(skin)<br />
NE 15 (skin) NE NE NE NE DFG MAK:<br />
Danger of<br />
cutaneous<br />
absorption<br />
Dibasic Potassium Salt NE NE NE NE NE NE NE NE<br />
Monobasic Potassium Salt NE NE NE NE NE NE NE NE<br />
Sodium Salt NE NE NE NE NE NE NE NE<br />
COMPONENT 11: Code WG#-MSM<br />
Deoxyadenosine Salt NE NE NE NE NE NE NE NE<br />
Deoxycytidine Salt NE NE NE NE NE NE NE NE<br />
Deoxyguanosine Salt NE NE NE NE NE NE NE NE<br />
Deoxythymidine Salt NE NE NE NE NE NE NE NE<br />
Aliphatic Triol 10<br />
(mist)<br />
NE 15 (total dust)<br />
5 (resp. frac.)<br />
10 (total dust)<br />
5 (resp. frac.)<br />
[vacated<br />
1989 PEL]<br />
NE NE NE NE DFG MAKs:<br />
TWA = 50<br />
(inhalable<br />
fraction)<br />
PEAK = 2•MAK<br />
15 min.<br />
average value,<br />
1-hr interval, 4<br />
per shift<br />
Pregnancy Risk<br />
Group C<br />
Glycol Homopolymer NE NE NE NE NE NE NE NE<br />
Carbohydrate 10 NE 15 (total<br />
dust); 5 (resp.<br />
frac.)<br />
NE<br />
10 (total<br />
dust); 5<br />
(resp. frac.<br />
NE NE NE<br />
Alkanolamine NE NE NE NE NE NE NE NE<br />
NE = Not Established. See Section 16 for Definitions of Other Terms Used